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Small-angle neutron diffraction (SAND)
Small-angle neutron scattering (SANS)
Molecular Dynamics simulationsThe cell membrane plays an important role in the molecular mechanism of amyloid toxicity associated with
Alzheimer's disease. The membrane's chemical composition and the incorporation of small molecules, such as
melatonin and cholesterol, can alter its structure and physical properties, thereby affecting its interaction with
amyloid peptides. Both melatonin and cholesterol have been recently linked to amyloid toxicity. Melatonin has
been shown to have a protective role against amyloid toxicity. However, the underlying molecular mechanism
of this protection is still not well understood, and cholesterol's role remains controversial. We used small-angle
neutron diffraction (SAND) from oriented lipid multi-layers, small-angle neutron scattering (SANS) from
unilamellar vesicles experiments andMolecular Dynamics (MD) simulations to elucidate non-speciﬁc interactions
of melatonin and cholesterol with 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) model membranes. We conclude that melatonin decreases the thickness of
both model membranes by disordering the lipid hydrocarbon chains, thus increasing membrane ﬂuidity. This re-
sult is in stark contrast to the much accepted ordering effect induced by cholesterol, which causes membranes to
thicken.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The cellmembrane is theﬁrst line of defense against invading species,
and is key to understanding disease, including amyloid toxicity that is
commonly associated with Alzheimer's disease. Small molecules, such
as cholesterol and melatonin incorporate into the lipid matrix and are
known to alter the membrane's structure and physical properties [1,2].
These changes to the membrane subsequently affect its functionality
and its interactionswith biomolecules.While the interaction of cholester-
ol with membranes has been extensively studied, the effect of melatonin
on the structure of lipid membranes is not well understood. Structural
studies detailing the effects of melatonin and cholesterol on membranes
are, however, of great importance because both molecules have been
linked to amyloid toxicity associated with Alzheimer's disease.
Alzheimer's (AD) is a neurodegenerative disease and a major form
of dementia that becomes more prevalent with increasing age. AD is
associated with the formation of plaques and insoluble amyloidnd Astronomy, University of
o).
rights reserved.ﬁbrils, which are composed of amyloid-beta (Aβ) proteins folded
into β-sheets, and which are found on the surface of neuronal plasma
membranes [3]. Recent studies have shown the lipid membrane to be
extremely important in enabling amyloid ﬁbril formation and its ensu-
ing toxicity [4–6].
In both human and animal studies melatonin has been shown to
have a protective role against AD, namely slowing the progress of
the disease [7–10]. However, the underlying molecular mechanism
of this protective effect is not well understood. Melatonin is a pineal
hormone that is produced in the human brain and is responsible for
maintaining the circadian rhythm and regulating the sleep–wake cycle
[11]. In addition to its well-known anti-oxidative effects, melatonin is
known for its involvement in intracellular signal transduction, regulation
of cell death and cell proliferation [12]. The protective mechanism of
melatonin against ADmay involve a nonspeciﬁc interaction of themole-
cule with themembrane [1]- although its effects on lipidmembranes re-
main inconclusive and controversial. It has also been reported that
melatonin decreases the gel-to-ﬂuid phase transition temperature in a
number of different lipid systems, implying that melatonin increases
membrane disorder [1,13–16]. In contrast, slower membrane dynamics
have been reported in DPPC bilayers [1], rat brain homogenate [17,18],
and in DMPCmembranes [15,19]. Garcia et al. reported on the stabilizing
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brane [20]. These important, but somewhat contradictory results there-
fore necessitate further studies regarding melatonin's effects on
biologically relevant membrane systems.
Although a number of in vitro studies have demonstrated the
above-mentioned protective effects of melatonin against Aβ, including
studies at the cellular level [10,21,22], the underlying mechanisms of
melatonin's protective action have yet to be adequately explained. For
example, Galano et al. emphasized the importance of the antioxidant
action of melatonin [23]; Bongiorno et al. have shown that melatonin
may compete with cholesterol for binding to lecithin, and that it may
even displace cholesterol from the phospholipid bilayer [2]. Melatonin's
ability to control cholesterol content, ergo membrane rigidity, may thus
reduce the effects of cholesterol on the membrane, as well as
cholesterol-mediated processes [9]. Previous studies [1–9,11–13,15,16]
have demonstratedmelatonin's ability to non-speciﬁcally bind to and in-
teract with the lipidmembrane, and to alter its biophysical properties. In
addition to its antioxidative protection, the biophysical effects of
melatonin on the membrane may also contribute to its cell protective
qualities and thus deserve further investigation. In this studywe spe-
ciﬁcally focus on the non-speciﬁc biophysical effect of melatonin on
model membranes with the purpose of comparing it to the effect by
cholesterol.
In contrast to melatonin's protective abilities, it has been shown
that cholesterol, when in a membrane, can enhance amyloid binding
and ﬁbril formation [24]. However, depending on the type of lipid and
amyloid peptide, others have reported that cholesterol hinders the
insertion of amyloid peptides into lipid membranes [25]. We have re-
cently shown that cholesterol induces non-homogeneous binding of
the amyloid peptide to the lipid membrane, resulting in the formation
of membrane defects [26]. Sheikh et al. also reported enhanced mem-
brane solubilization and defect formationwhen cholesterolwas present
in model membranes [27]. On the cellular level, cholesterol has been
shown to reduce the toxic effect of amyloid plaques on neuroblastoma
cells [28]. Therefore, in order to better understand how melatonin
and cholesterol affect the interaction of biomolecules – e.g., amyloid
ﬁbrils –with themembrane, it is necessary to systematically determine
the effects that these molecules have on membrane structure.
Cholesterol is a well-known sterol that usually orients itself parallel
to bilayer lipids, the exception being in bilayers with polyunsaturated
fatty acids, where cholesterol sequesters into the middle of the bilayer
(i.e., orthogonal to the bilayer normal) [29]. According to the lipid raft
hypothesis, cholesterol is an important constituent of lipid rafts
[30–34]. Rafts saturated with cholesterol and sphingolipids, as well as
saturated lipids such as 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), are thought to compartmentalize certain cellular processes,
including cell signaling, molecular assembly andmembrane protein traf-
ﬁcking, and require the presence of cholesterol in order to form
[31,32,35]. Cholesterol has also been shown to affect membrane perme-
ability and ﬂuidity, as well as the mechanical properties of model mem-
branes [31,32,36–38]. Factors affecting cholesterol's inﬂuence on
membranes include its concentration and membrane composition
[32,39,40].
Neutron scattering has been extensively used to study the structure
of model lipid membranes. The technique has been employed to accu-
rately determine bilayer structural parameters (e.g., lipid area, bilayer
thickness), cholesterol's location in multilayers, and its interactions
with different lipids, to name a few [41–45]. To the best of our knowl-
edge, neutron scattering has not been previously used to study the
effect of melatonin on model membranes, nor how cholesterol's effects
on membranes differ from those of melatonin. Moreover, there are
no computer simulation studies of the effect of melatonin on mem-
branes. We believe this to be the ﬁrst study to address the molecular
mechanisms of melatonin–lipid and melatonin–cholesterol–lipid in-
teractions using Molecular Dynamics (MD) simulations in compari-
son with neutron scattering experiments.2. Materials and methods
2.1. Sample preparation
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC), melatonin and cholesterol were
purchased from Sigma-Aldrich (St. Louis, MO) in powder form. All
other chemicals used were of reagent grade.
Lipids were solubilized in a 1:1 solution of chloroform: TFE
(triﬂuoroethanol) with the requisite amount of cholesterol or melatonin
(reported here in molar fractions) placed in a glass vial at total lipid con-
centrations of between 25 and 30 mg/mL. Approximately 15 mg of pure
lipid; amixture of lipid and cholesterol; or amixture of lipid andmelato-
nin (thin ﬁlm thickness of ~0.001 cmwhen spread onto a 25 × 60 mm2
silicon wafer), was deposited onto a silicon wafer and rocked during
evaporation of the organic solvent in a glove box to form samples of
highly oriented multilayer stacks [46]. The remaining solvent was re-
moved by placing the oriented samples under vacuum prior to diffrac-
tion measurements.
Samples of unilamellar vesicles (ULVs) were prepared for study
by small angle neutron scattering (SANS). Lipids were mixed with
cholesterol/melatonin in chloroform, and then solutionswere dried, ini-
tially in a stream of inert gas (e.g., Ar or N2), and subsequently under
vacuum. The resulting lipid ﬁlm was hydrated using the requisite
amount of 100% D2O resulting in a solution with a total lipid concentra-
tion of 20 mg/mL. The dispersions of self-assembled multilamellar
vesicles (MLVs) were then extruded through polycarbonate ﬁlters pop-
ulated with 50 nm pores using an Avanti Extruder (Avanti Polar Lipids,
Alabaster, AL). This procedure has been shown to yield reasonably
monodisperse ULVs with a mean diameter of ~60 nm [47].
2.2. Small-angle neutron diffraction
Neutron diffraction data were collected at the Canadian Neutron
Beam Centre's (CNBC) N5 beamline, which is located at the National
Research Universal (NRU) reactor (Chalk River, Ontario, Canada).
Neutrons of 0.237 nmwavelengthwere selected by the (002) reﬂection
of a pyrolytic graphite (PG)monochromator, and a PG ﬁlter was used to
eliminate higher order reﬂections. Incoming neutrons were collimated
into a rectangular beam of dimensions 6 × 50 mm2, and scattering
angles were determined via the sample angle θ and the detector angle
Φ. Samples were placed in an airtight sample cell and hydrated with
saturated K2SO4 (97% relative humidity) solutions using a series of dif-
ferent neutron contrast D2O/H2O mixtures (i.e., 70%, 40%, and 8% D2O)
at 25 °C.
Sample stability over the duration of the experiment was conﬁrmed
through the reproducibility of the diffraction data, whereby lamellar re-
peat spacings and peak intensities (i.e., for a given quasi-Bragg reﬂection)
remained constant, indicating that bilayer structurewas unaltered. Align-
ment quality for each sample was assessed using the Gaussian width of
rocking curves (i.e., the sample was rotated through an angle θ, while
the detector remained ﬁxed at a given angle (Φ)). Fig. 1 shows a typical
rocking curve with a sharp central peak (mosaic spread of Gaussian
width ~0.05°) corresponding to large lateral domains of highly oriented
multi-bilayers [48]. This narrow peak sits atop a broad peak (Gaussian
width ~0.5°) consisting of scattering from much smaller domains with
a broader distribution of orientations [49].
Diffraction curves were obtained using θ–2θ scans, i.e., where the
detector is always positioned atΦ = 2θ. Typicallyﬁvequasi-Bragg orders
were detected, which were ﬁtted to Gaussians and an additional second-
order polynomial function associatedwith the background. Integrated in-
tensities for the different quasi-Bragg peaks were corrected for incident
neutron ﬂux, sample absorption and the Lorentz correction, as described
elsewhere [48]. The phases of the corrected form factors were deduced
through the systematic substitution of H2O by D2O in the hydrating solu-
tion, whereby the bilayer form factors measured at different contrast
Fig. 1. Semi-log plot of a rocking curve (points) corresponding to theﬁrst order diffraction
peak from aligned multi-bilayers (DOPC with 9 mol% melatonin). The width of the peak
(gray lines) indicates the quality of the sample's alignment. Note that the neutron signal
drops at two locations along the curve, both as a result of increased neutron absorption,
which occurs when the sample is parallel to the incident (i.e., θ = 0) or the diffracted
(i.e., θ = Φ) neutron beam.
Fig. 2. Log–log plot of SANS data obtained for A) DPPC bilayers doped with different
amounts of cholesterol (data from the N5 instrument) and B) DOPC bilayers doped
with melatonin (measured on the CG-3 Bio-SANS instrument). The blue solid lines
are best ﬁts to the data (open symbols). The SANS curves are shifted from each other
(by a factor of 4) for better visualization.
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Neutron Scattering Length Density (NSLD) proﬁles were calculated via
the Fourier transform of the scattering form factors, while absolute
scale NSLD proﬁles were not determined. This procedure results in
NSLD proﬁles that can be used to determine the characteristic features
of bilayers. Moreover, the proﬁles obtained for samples hydrated
with 8% D2O solution show only the bilayer, and are not obscured
from scattering by the solvent (in 8% D2O the water contribution to
the NSLD is practically zero). These proﬁles are thus best used to ex-
tract the membrane's ﬁne structural details (i.e., lipid head-groups
peak–peak distance across the bilayer, DHH).2.3. Small-angle neutron scattering
Neutron scattering data were collected at CNBC's N5 triple-axis
spectrometer, which was adapted for SANS measurements [51], and at
the CG-3 Bio-SANS instrument [52] located at Oak Ridge National
Laboratory (ORNL). In the case of the N5 instrument, 4 Å wavelength
neutrons were selected using a PG monochromator, and the scattered
neutrons were detected using a 32 wire detector positioned at ﬁve
predetermined angles (i.e., Φ = 1.5, 3.3, 5.1, 6.9, and 8.7) covering a
scattering range of 0.008 Å−1 b q b 0.270 Å−1. In the case of the CG-3
instrument, 6 Åwavelength neutronswere selected using amechanical
velocity selector, and two different sample-to-detector distances
(i.e., 2.5 and 15.3 m) were used, covering a total scattering vector
of 0.004 Å−1 b q b 0.370 Å−1. The two different experimental
setups provided data of comparable quality (see Fig. 2), although the
dedicated CG-3 instrument resulted in higher quality high q data.
SANS measurements were carried out using ULVs dispersed in a
100% D2O solution — as opposed to H2O. D2O is often used in neutron
experiments in order to decrease the large incoherent scattering that
results from hydrogen atoms, and to increase the contrast between the
hydrating water and the lipid bilayer —which is also rich in hydrogen.
As a result, the system is best described by a three component strip
model made up of pure water (outside the lipid bilayer), a bilayer
core of pure hydrocarbons, and a region where the lipid head-groups
are inter-dispersed with water. This type of strip model analysis [53]
has been used successfully to study the effect of cholesterol on DOPC
bilayers [38]. However, in the present study we substituted the sharp
interfaces separating the adjacent strips with smooth error functions
that represent a more realistic picture of membranes [54]. As a result,
we report a bilayer thickness that corresponds to the steric thickness
of the bilayer. It should be noted that this thickness is different from
the DHH obtained from SAND (described above), and is thus more ap-
propriate to focus on the relative changes taking place within thesedifferent membrane thickness parameters, rather than their absolute
values.
2.4. Computational membrane modeling
We modeled phospholipid membranes with melatonin using at-
omistic MD simulations. Each systemwas composed of 512 lipid mole-
cules, approximately 28,000 water molecules were added to achieve
full hydration, along with 72 molecules of melatonin (for 12 mol%).
The GROMACS software package [55] with the GROMOS 53a6
force-ﬁeld [56] was used in the simulations. The GROMOS 53a6
force-ﬁeld was used because it has been tested and validated for lipid
and peptide systems [57,58]. Corrections by Bachar et al. were used
for acyl double bonds as they have been shown to be important for
proper modeling of sterol–lipid interactions [59]. New partial charges
were determined for melatonin by quantum mechanical calculations
using the Fireﬂy (PC GAMESS) 7.1.G program [60]. The ﬁnal parameter-
ization of melatonin was computed using restricted Hartree–Fock type
self-consistent ﬁeld calculations in order to ﬁnd the optimal starting ge-
ometry, as well as the partial charges. A Pople split valence basis set
with 6 primitive Gaussians for the atomic cores, along with a combina-
tion of two basis functions to form valence orbitals comprised of 3 prim-
itive Gaussians for the ﬁrst valence orbital and 1 primitive Gaussian for
the second orbital were used. A single polarization function was added
to both heavy and light atoms (6-31dp), and the simple point charge
(SPC) model was used for water. Bond lengths were constrained using
the SETTLE [61] algorithm for water, and LINCS [62] for the lipids.
Lennard-Jones interactions were treated with a switching algorithm
that started at 0.8 nm and used a cutoff of 0.9 nm. Electrostatics were
treated with the particle-mesh Ewald method [63,64] using a real
space cutoff of 1.4 nm, beta spline interpolation (of order 4), and a di-
rect sum tolerance of 1E-6. Periodic boundaries were used in all three
dimensions, along with a 2 fs time step. The systemswere set up by ar-
ranging 64 lipids per leaﬂet on a rectangular lattice. Steepest decent en-
ergy minimization was done before adding water, and then repeated.
This was followed by a 100 ps NVT relaxation at 273.15 K using a
Fig. 4. Neutron Scattering Length Density (NSLD) proﬁles of DOPC bilayerswith increasing
concentrations of cholesterol (A) and melatonin (C), as well as DPPC with increasing con-
centrations of cholesterol (B) and melatonin (D). Proﬁles are of bilayers hydrated with 8%
D2O, and deliberately centered at z = 0 Å to allow for the direct comparison of the lipid
head-group peak–peak distance (DHH) of the different samples.
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For DPPC, a further relaxation (far above Tm =314 K) was carried out
at 410 K for 20 ns before returning to 300 K. A ﬁnal relaxation of
100 ns NpT simulation was carried out at 300 K and 1 bar. The produc-
tion simulations were conducted in the NpT ensemble. Pressure and
temperature were ﬁxed at 1 bar and 300 K, respectively, using the
Parrinello–Rahman algorithm [65] with a relaxation time of 0.5 ps, in
the case of pressure, and the Parrinello–Donadio–Bussi v-rescale algo-
rithm [66] for temperature coupling with a relaxation time of 0.1 ps.
The temperatures of the lipids and water were coupled independently.
This simulation protocol has been shown to be reliable for membranes
and other related systems [57].
3. Results and discussion
In order to determine how melatonin affects membrane structure,
and to compare these changes to those induced by cholesterol, we
created a model of simpliﬁed bilayers containing either melatonin or
cholesterol. It is well known that cholesterol when incorporated
into a lipid bilayer partitions into the hydrocarbon chain region with
its hydrophilic hydroxyl head-group residing in close proximity to the
lipid head-groups [67–69] (Fig. 3A). It has also been proposed that
melatonin may integrate itself into the head-group region of the
lipid bilayer [16], as shown in Fig. 3B.
Our SAND data obtained from oriented stacks of multi-bilayers, and
SANS data from ULV dispersions provide a more detailed description of
the changes in bilayer structure incurred by the incorporation of
cholesterol or melatonin into a lipid bilayer.
Fig. 4 shows the NSLD proﬁles of lipid bilayers obtained from
SAND measurements. In the case of these samples, varying amounts
of cholesterol, or melatonin, were added (in equivalent molar ratio
amounts), and the samples were hydrated using solutions with different
neutron contrasts. The 8% D2O solution results in NSLD proﬁles whose
scattering can be exclusively attributed to the lipid bilayer, with no con-
tribution from the bulk water.
The bilayer thickening effect as a result of cholesterol is well doc-
umented [38,48,50,69] and our results (Fig. 4A and B) are in good
agreement with previous published data. Fig. 4A and B clearly illus-
trate the changes taking place in the lipid head-group peak-to-peak
distance (DHH) as a function of increasing amounts of cholesterol in
DOPC (Fig. 4A) and DPPC (Fig. 4B) bilayers. DHH is a good indicator
of bilayer thickness and corresponds to the distance separating head
groups from opposing bilayer leaﬂets. It is clear that DHH progressive-
ly increases with increasing amounts of cholesterol in the case of both
bilayers (Fig. 4A and B). Although cholesterol does not initially result
in any signiﬁcant change to DHH, this change becomes more pro-
nounced with increasing amounts of cholesterol. In the absence of
cholesterol, the DHH of the DOPC bilayer (Fig. 4A) is 33.9 Å, and in-
creases to 34.7 Å and 37.1 Å at 9% and 29% cholesterol, respectively.
A similar trend of increasing thickness is seen in DPPC bilayers
(Fig. 4B): DHH of the pure DPPC bilayer is 39.2 Å, and increases to
39.4 Å and 44.8 Å at 9% and 28% cholesterol, respectively.Fig. 3. Schematics illustrating the proposed locations of cholesterol and melatonin in
the lipid membrane: (A) cholesterol, (B) melatonin.Fig. 4C and D show NSLD proﬁles for DOPC and DPPC bilayers,
respectively, with increasing amounts of melatonin. In contrast to the
effect by cholesterol, increasing amounts ofmelatonin in the lipid bilayer
result in a progressive decrease in lipid bilayer thickness.
In the case of DOPC bilayers, for example, DHH decreases from
33.9 Å in pure DOPC bilayers to 33.5 Å and 32.0 Å in DOPC bilayers
with 9% and 29% melatonin, respectively (Fig. 4C). In DPPC bilayer
with the lowest concentration of melatonin studied here (9%), it ap-
pears that melatonin causes only a slight increase in DHH — i.e., pure
DPPC has a DHH of 39.2 Å, while DPPC with 9% melatonin increases to
39.6 Å. However, due to difﬁculties in preparing oriented DPPC samples,
we were not able to obtain good quality data from DPPC bilayers with
higher concentrations of melatonin. Therefore, we only used the data
from ULV samples to report on how increasing amounts of cholesterol
affected the DHH of DPPC bilayers.
SANS data from ULV samples have been successfully used to study
cholesterol's effects on DOPC bilayers [38,48]. As mentioned, SANS
experiments were carried out using ULVs dispersed in 100% D2O in
order to improve the scattering contrast between the lipid bilayer
and its surrounding water. By ﬁtting the SANS data with an appropriate
model, one can obtain NSLD proﬁles that differ from the ones obtained
from oriented stacks of bilayers hydratedwith 8% D2O solution. In other
words, in the ULV case with 100% D2O, the water molecules are an
integral part of the overall bilayer structure. As such, the obtained bilay-
er thickness (DS) corresponds to the bilayer's steric thickness, which
also includes the water molecules penetrating the bilayer's head-
group region.
Analysis of the ULV cholesterol data obtained by SANS is in agree-
ment with the data obtained from the diffraction experiments. Bilayer
thickness DS increases with increasing cholesterol concentration for
both DOPC (Fig. 5A) and DPPC bilayers (Fig. 5B). In the case of DPPC
bilayers (Fig. 5B), DS increases from 57.0 Å, to 59.6 Å, and to 60.2 Å
at 0%, 9% and 28% cholesterol, respectively. This result agrees well
Fig. 5. Neutron Scattering Length Density proﬁles. The plots are results of ﬁtting a smooth
stripmodel to SANS data fromDOPC (A) (adapted from [30]) and DPPC (B) (data from the
N5 instrument) bilayers with increasing amounts of cholesterol. Panels C and D show the
effect of melatonin on DOPC and DPPC bilayers, respectively (measured on the CG-3
Bio-SANS instrument). ULVs were extruded in 100% D2O.
Fig. 6. Thicknesses of DOPC (top) and DPPC (bottom) bilayers upon the addition of
cholesterol (left) and melatonin (right). Blue circles represent changes to the DHH
thickness obtained from SAND, while green squares correspond to changes in the DS
thickness obtained from SANS. Black lines are ﬁts to the data.
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monounsaturated phosphatidylcholine bilayers, where lipid chain or-
dering increases as a result of interactions with the rigid cholesterol
molecule.
Importantly, our SANS studies of DOPC and DPPC bilayers with in-
creasing amounts of melatonin show that both membranes undergo
progressive thinning as a function of increasing amounts of melatonin
(Fig. 5C and D respectively). In the case of pure DOPC, DS has a value of
51.3 Å, which decreases to 50.1 Å and 49.1 Å upon the addition of 9%
and 28% melatonin, respectively. A similar thinning trend is observed
for the DPPC systems: the pure DPPC bilayer has a DS of 56.3 Å, but
the addition of 9% and 28%melatonin caused DS to decrease, respectively
to 55.0 Å and 49.0 Å. This result supports the notion that melatonin in-
corporates itself into the bilayer's head-group region, as shown in
Fig. 3B. According to this scheme, melatonin acts as a spacer between
lipid head-groups, causing the free volume in the bilayer's hydrocarbon
region to increase. This free volume is then readily taken up by the
disordered hydrocarbon chains at the expense of their effective length
(i.e., reduced bilayer thickness).
Fig. 6 summarizes the different neutron data. Although it has been
pointed out that the two bilayer thicknesses (i.e., DHH and DS) differ in
their deﬁnition, their relative changes are directly comparable. Fig. 6
shows that there is very good agreement between DHH and DS as a
function of increasing concentration of cholesterol or melatonin —
i.e., increased amounts of cholesterol cause the bilayer to thicken,
while melatonin has the exact opposite effect on bilayer thickness.
Lipidmembrane thickness is a structural parameter that is needed to
accurately determine other bilayer structural parameters and is directly
related to lipid–lipid, and lipid–protein interactions in biomembranes.
Our experimental results conﬁrm the previously reported and well-
known bilayer thickening effect induced by cholesterol (see Fig. 6).
This, as a result of the hydrocarbon chains experiencing increased
order due to their interactions with the rigid cholesterol molecules. In-
terestingly, our experimental results show, for the ﬁrst time, that theaddition of melatonin has the exact opposite effect, i.e., melatonin
causes bilayer thinning (Fig. 6). This is most likely due to melatonin in-
troducing disorder within the membrane by increasing the area per
lipid as it incorporates itself among the lipid head-groups. This notion
is also supported by the encroachment of water molecules deeper into
the membrane (shown in Fig. 5C and D).
In order to further elucidate the structural details on the effect of
melatonin and cholesterol on model lipid bilayers, we performed MD
simulations. In agreement with our experimental SANS and SAND
data, MD simulations show that cholesterol increases the acyl chain
order of both DOPC and DPPC bilayers. In contrast to cholesterol, mela-
tonin decreases the order in both bilayers (Fig. 7).
Fig. 7 illustrates the structure of DPPC and DOPC bilayers with and
without melatonin. At 300 K, pure DPPC bilayers are in the gel phase
(Tm of DPPC is 314 K). Theﬁgure clearly demonstrates that the presence
of melatonin induces local disorder in the lipid tails, i.e., it melts the gel
phase of the pure DPPC system (Fig. A vs Fig. 7B). The pure DPPC system
has a number of lipids in the liquid phase (Fig. 7A). This is due to the fact
that the time it takes to complete the phase transition is longer than the
simulation time. The melatonin-containing system, however, is differ-
ent (Fig. 7B): all of the melatonin containing regions are in the liquid
phase, i.e., melatonin increases the ﬂuidity of the system- the patches
that do not contain melatonin remain in the gel phase. Since for DOPC
the main transition temperature is lower, Tm = 253 K, it is already in
the liquid state (Fig. 7C), therefore the effect of melatonin is readily ap-
parent (Fig. 7D). To determine whether or not melatonin has a further
ﬂuidizing effect onDOPCwe investigated the occurrence of bilayer thin-
ning and changes to area per lipid.
MD data in Fig. 8 show that melatonin's (orange line) preferred
location is just inside the crossover region describing the lipid head
groups and the fatty acid chains. Fig. 8 shows that for DPPC (Fig. 8A)
bilayers the peak density is decreased when melatonin is present. For
DOPC (Fig. 8B), the peak density of the lipid tails is increasedwhenmel-
atonin is added (solid lines: nomelatonin, dashed lines: withmelatonin).
In our DPPC simulations, the thickness of the membrane increased with
the addition of melatonin from DHH = 39.8 ± 0.1 Å to 40.9±0.5 Å. For
DOPC, the thickness went from DHH = 37.0 ± 0.1 Å to 37.6 ± 0.5 Å
after melatonin was added. The area of the pure DOPC bilayer was
67.4 ± 0.4 Å2. The addition of melatonin increased this value to
69.4 ± 0.5 Å2. The trends observed upon the addition of melatonin
are in excellent agreement with our experimental results. In addition,
the trends observed in neutron scattering upon addition of choles-
terol are in perfect agreement with previous simulations [70,71].
Thus, we can conclude that the simulations provide an accurate pic-
ture of melatonin's location and effect for both DPPC and DOPC bilay-
ers: melatonin interacts with the lipid head groups and does not
penetrate into the hydrophobic core.
Fig. 7.Molecular Dynamics simulations of DPPC and DOPC bilayers with andwithout melatonin. DPPC (top) and DOPC (bottom) bilayers. Left: pure systems: A—DPPC, C—DOPC. Right:
with melatonin: B— DPPC–mel, D— DOPC–mel. Melatoninmolecules are shown in orange. Snapshots were taken after 400 ns of MD simulation at T = 300 K. The total simulation time
for each systemwas 500 ns. Note the gel phase on the left hand side in the pure DPPC system (for DPPC, Tm = 314 K). Melatonin appears to enhance and maintain local ﬂuidity. This is
clearly visible in the DPPC membrane with melatonin (top right). Since the DOPC system is above its main phase transition (Tm = 253 K), the effects of melatonin are more subtle.
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show that the effect of melatonin on bilayer thickness is opposite to
that of cholesterol. Both experimental data and MD simulations
show that cholesterol has an ordering effect, and increases bilayer
thickness. In contrast to cholesterol, melatonin decreases the order
and decreases the thickness of both bilayers, thus inducing increased
ﬂuidity in the model membrane. These observations may prove to be
important for other studies on amyloid toxicity, as they may lend
some insight into understanding the molecular mechanism of
melatonin's protection in Alzheimer's disease. For example, melato-
nin levels in the body have been shown to decrease with age [72].
As Alzheimer's disease is more prevalent later in life, the effects of
melatonin and cholesterol on lipid membrane become increasingly
important as their amounts in membranes also change with age.
Both cholesterol and melatonin have implications in amyloid toxicity
and Alzheimer's progression in animal and cell studies [4,12] -al-
though themolecularmechanism of their action is not well understood.
Considering the role of the cell membrane in amyloid toxicity, it is also
important to note that amyloid deposits are known to affect the synapse
[73,74], where membrane ﬂuidity is important for the propagation of
the action potential signal from one neuron cell to another, which oc-
curs through the fusion of synaptic vesicles. Our results can, for the
ﬁrst time, provide an understanding for the possible structural
changes taking place within biological membranes. The effects of
melatonin on membrane structure may have consequences similar
to those of cholesterol reducing drugs. Studies have also shownFig. 8. Density proﬁles for one bilayer leaﬂet calculated fromMD simulations of DPPC (A) and D
are represented by solid lines, and ones with melatonin by dashed lines. Black: total density, rthat membrane cholesterol levels may regulate the toxic effects of
amyloid beta, and that cholesterol reducing agents such as
mevastatin, methyl-β-cyclodextrin or ﬁlipin, are able to reverse or
diminish such toxic effects [75]. Melatonin has also been shown to
signiﬁcantly decrease cholesterol absorption and total cholesterol
levels [76], in addition to its ability in reducing amyloid toxicity. Am-
yloid toxicity is directly related to the damage that amyloid produces
in cell membranes. We have also shown previously [26] that amyloid
binding, the ﬁrst step in amyloid toxicity [77], is affected by choles-
terol, i.e., the presence of cholesterol increases damage to the mem-
brane, and in good agreement with data by Sheikh et al. [27].
Choucair et al. also reported that the phase of the lipid membrane
is important for amyloid binding and demonstrated that the amyloid
peptide preferentially binds to thicker and less ﬂuid membranes
[78].
In summary, we have shown that melatonin decreases bilayer
thickness and increases the head group area, resulting in more ﬂuid
and disordered bilayers, in contrast to the well-known condensation
effect induced by cholesterol. Based on our results, we hypothesize that
melatonin may counteract cholesterol's membrane ordering effect, and
thus may affect amyloid binding, which leads to membrane damage
associatedwith amyloid toxicity. The present results help in understand-
ing the mechanism by which cholesterol and melatonin may affect the
properties of biological membranes, and they could be used to better
comprehend the mechanism of interaction of membranes with amyloid
peptides in relation to amyloid toxicity and AD.OPC (B) membranes at T = 300 K. Zero denotes the membrane center. Pure membranes
ed: solvent, green: head groups, and blue: lipid tails, and orange: melatonin.
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